More than 120,000 people are missing in Mexico. After a cartel camp's gruesome discovery, families of the disappeared turn to ...

an LRRC15 antibody-drug conjugate (ADC) for the treatment of sarcoma, and ZL-1222, a PD-1 targeted IL-12 immunocytokine for cancer immunotherapy, will be presented during poster sessions at the ...

"Among these, we are excited to share updates on ZW209, our DLL3-targeting trispecific T cell engager incorporating co-stimulation, which is on track for IND submission in 1H-2026, and ZW327, our Ly6E ...

New antibody-drug conjugate (ADC ... today announced the acceptance of six abstracts for poster presentation at the upcoming American Association for Cancer Research (AACR) Annual Meeting being ...

Unfortunately you've used all of your gifts this month. Your counter will reset on the first day of next month.

Insmed Incorporated , a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced ...

Investing.com - US stock futures were trading in negative territory during Sunday's evening deals, following a mixed week for benchmark averages amid mixed inflation data and major financial ...

The Company's complementary therapeutic platforms and fully integrated drug development engine provide the flexibility and compatibility to precisely engineer and develop highly differentiated ...

Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an encouraging safety profile New antibody-drug conjugate (ADC) candidate ...

Investing.com-- The S&P 500 fell Wednesday, as investors hit pause on the recent rally and awaited further catalysts including key inflation data later this week. At 4:00 p.m. ET (2000 GMT), Dow ...